Enlivex Completes Patient Enrollment In Its Phase I/II Clinical...
Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital,...
- Medivation And Pfizer Announce Results From Phase 3 Concert Trial Of Dimebon In...
- Inviragen Initiates A Phase 2 Clinical Study Of DENVax, A Recombinant, Tetravalent...
- Combination 'Epigenetic' Therapy May Restore Anti-Cancer Gene Activity In Late-Stage ...
- Unigene Announces Novartis' Disclosure Of First Interpretable Results From Phase 3...
- Del Mar Pharmaceuticals Initiates Glioblastoma Clinical Trial
Efficient Contracting Processes For Clinical Trials ... From The ...
On Dec. 1, 2011 in Cambridge, MA, law firm Pepper Hamilton's Timothy Atkins, partner, life sciences, and Jason Reiser, associate, life sciences, gave a presentation as part of the...
- The Irish Department Of Agriculture Gains Improved Efficiencies And Strategic...
- The Evolving Role Of Pharmacovigilance
- Biobetters Q&A
- Gene Expression Diagnostics: A New Approach
Clinical Trial Manufacturing
The Clinical Trial Manufacturing area at our Spokane facility is available for production of Phase I through commercial material with 2,100 ft2 of production space.
- Lyophilization
- Getinge cGMP Washer/Dryers
- DASGIP pH Monitoring Modules
- Predictive Biomarkers
- Mineral Membranes & Systems: Kerasep®- Bio Membranes and Systems
Services
Upcoming Events
-
The EU Clinical Trial Directive
May 21 - 22, 2012
King of Prussia, PA - UNITED STATES -
Clinical Document Management - A Trial by Trial Approach to Compliance
March 1 - 2, 2012
Los Angeles, CA - UNITED STATES -
Vaccine World Summit
March 12 - 16, 2012
Hyderabad - INDIA
More...
Quick Searches
Guest Column
-
Executive Insights Into Single-Use: Barbara Paldus Of Finesse
Barbara Paldus, CEO, Finesse, LLC, joined an executive roundtable with Rob Wright of Life Science Leader magazine to discuss single-use technology. The intent -- gain a better understanding of the impact single-use technologies has on the biopharmaceutical manufacturing industry and the environment. Enjoy Paldus' executive insights with regard to single-use for all nine of the questions posed to the original roundtable. -
Article: How To Choose An Industrial Cation Exchanger For IgG Purification
Cation-exchange chromatography is the third most used industrial method for antibody purification after anion-exchange and protein A affinity chromatography. It is most commonly used as an intermediate step but continues to attract attention as a capture method. By Pete Gagnon